A New Standard for Rapid Microbiological Testing

BioSense Technologies has developed a new rapid method for determining the  physiological status of cells. The company is using this technology to detect bacteria and other pathogens and determine their susceptibility to therapeutic agents in real-time. Our goal is to improve the diagnosis and treatment of infectious and other diseases and prevent the development and spread of antibiotic resistance.